Should we transplant or not in frontline therapy for MCL?

Описание к видео Should we transplant or not in frontline therapy for MCL?

Tycel Phillips, MD, of the University of Michigan, Ann Arbor, MI, discusses if we should transplant or not in frontline therapy for mantle cell lymphoma (MCL) at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Комментарии

Информация по комментариям в разработке